Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants
Editorial Group: Cochrane Neonatal Group
Published Online: 31 MAY 2013
Assessed as up-to-date: 2 MAR 2013
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
More K, Athalye-Jape G, Rao SC, Patole SK. Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD010531. DOI: 10.1002/14651858.CD010531.
- Publication Status: New
- Published Online: 31 MAY 2013
This is the protocol for a review and there is no abstract. The objectives are as follows:
- To assess the efficacy and safety of ETRA in the treatment of PPHN in full-term and late preterm infants.
- To assess the efficacy and safety of selective (which block only the ETA receptors) and non-selective (which block both ETA and ETB receptors) ETRA separately.